Group 1 - The company, Brainstorm Aurora-B (06681), has entered into a placement and subscription agreement, with a share placement price set at HKD 5.6 per share, representing a discount of approximately 12.09% from the last closing price of HKD 6.37 [1] - The placement shares will account for about 7.27% of the company's existing issued share capital as of the announcement date, and approximately 6.77% after the completion of the subscription [1] Group 2 - The total estimated proceeds from the subscription are approximately HKD 515 million, with a net amount expected to be around HKD 501 million after deducting all related costs and expenses [2] - The company plans to allocate approximately 50% of the net proceeds for research and development programs, including the development of non-invasive brain-computer interface systems and consumer-oriented digital health platforms, expected to be fully utilized by September 30, 2027 [2] - About 30% of the net proceeds will be used for domestic and international market development, including costs related to establishing national branches and supporting academic conferences, expected to be fully utilized by June 30, 2027 [2] - Approximately 10% of the net proceeds will be allocated for strategic investments and acquisitions within the digital health ecosystem, expected to be fully utilized by June 30, 2027 [2] - The remaining 10% will be used to supplement the company's general working capital, expected to be fully utilized by December 31, 2026 [2]
脑动极光-B(06681)拟折让约12.09%先旧后新配股 净筹约5.01亿港元